Classification of Pancreatic Carcinoma 膵癌取扱い規約 英語版 第4版

出版社: 金原出版
発行日: 2017-07-10
分野: 臨床医学:一般  >  癌/腫瘍一般
ISBN: 9784307203715
シリーズ: がん取扱い規約

4,400 円(税込)


各臓器の癌取扱い規約は我が国における癌の分類・記載法の標準として広く使われているが、これを日本発の情報として海外へ発信するために英語版の刊行が求められた。これに応じ、膵癌では1996年に日本語第4版に準拠した初の英語版が発行され、その後、日本語第5版準拠の第2版が2003年に、日本語第6版準拠の第3版が2011年に刊行された。本版は『膵癌取扱い規約 第7版』(2016年7月刊行)の全文英訳版である。


  • Classification of Pancreatic Carcinoma
    膵癌取扱い規約 英語版 第4版


    Dataset for histopathological reports for pancreatic cancer

    I. Introduction (purpose and the main disease covered)

    II. Principles of Recording Findings

    III. Description of Findings
     1. Primary tumor
      1) Tumor location
      2) Size and number of the tumors
      3) Macroscopic type
      4) Grade of local invasion
       (1) T category
       (2) Diagnostic imaging guidance for T category
       (3) CT imaging evaluating T category
          (comparison with the microscopic view)
     2. Lymph node metastases
      1) Identification of the lymph nodes
       (1) Station numbers,names,and boundaries of
          lymph nodes related to the pancreas
       (2) Lymph node numbers related to the pancreas and
          diagnostic CT criteria for lymph node metastasis
      2) Regional lymph nodes
      3) Recording lymph node metastases
       (1) Degree of lymph node metastasis (N)
       (2) Ratio of lymph node metastasis
     3. Distant metastases (M)
      1) Peritoneal metastasis (P)
      2) Hepatic metastasis (H)
     4. Staging
      TNM Clinical Classification of the
       UICC TNM Classification,8th edition (2016)
     5. Resectability classification
      1) Resectability
      2) Examples of CT images for resectability

    IV. Surgical Treatment
     1. Type of operative procedure
      1) Surgery with or without resection
      2) Method of operative approach
     2. Description of pancreatic resection
      1) Type of resection
      2) Combined resection
      3) Reconstructions
       (1) Reconstructions after PD,PPPD,or SSPPD
       (2) Type of pancreaticoenteric anastomosis
     3. Classification of lymph node dissections (D)
     4. Assessment of residual tumor (R)
      1) Pancreatic cut-end margin (PCM)
      2) Bile duct cut-end margin (BCM)
      3) Dissected peripancreatic tissue margin (DPM)

    V. Results of Treatment
     1. Number of patients with pancreatic cancer
     2. Prognostic survey
     3. Cause of death
     4. Mode of recurrence
     5. Survival rate

    VI. Handling of Resected Specimens
     1. Handling of resected pancreatic specimens
     2. Sectioning
      1) Pancreatoduodenectomy specimens
      2) Distal pancreatectomy specimens
      3) Total pancreatectomy specimens
     3. Method of performing peritoneal washing cytology

    VII. Histological Findings of Pancreatic Neoplasms
     1. International Classification of Diseases for
        Oncology (ICD-O) code
      [1] Epithelial neoplasms
      [2] Non-epithelial neoplasms
     2. Cancer-stroma relationship
     3. Growth patterns of neoplasms infiltrating
        surrounding tissue (INF)
     4. Lymphatic invasion (ly)
     5. Venous invasion (v)
     6. Nerve invasion (ne)
     7. Intraductal spread in MPD (mpd)
     8. Explanation of the histological classification
      [1] Epithelial neoplasms
      [2] Non-epithelial neoplasms
      ■Atlas of Pathology
       Exocrine Neoplasms
        Serous neoplasms
        Mucinous cystic neoplasm
        Intraductal neoplasms
        Pancreatic intraepithelial neoplasia (PanIN)
        Invasive ductal carcinomas
        Acinar cell neoplasms
       Neuroendocrine Neoplasms
       Epithelial Neoplasms of Uncertain Differentiation

    VIII. Biopsy/Cytology of Pancreatic Neoplasms
     1. Reporting of pancreatic biopsy/cytology
      ■Biopsy Histology
     2. Pancreatic cytology report
      1) Reporting format and diagnosis
      2) Classification of intraoperative peritoneal
         washing cytology (CY)
      3) Pancreatic neoplasms
      ■Cytological Atlas

    IX. Histological Assessment of
       Preoperative Therapeutic Effects
     Criteria for histological response to
      drug therapy/radiotherapy
     Histological findings following drug therapy/radiotherapy
     Example of histological assessment of preoperative
      therapeutic effects (Grade 2)